Moderna "Does Not Know How Many Doses Went Into Arms" In California Adverse Vax-Reaction Cluster Update (1300ET): Moderna has issued a statement addressing the disturbing number...
With multiple COVID-19 vaccines being distributed across the world, companies focused on other medical conditions are grabbing the Street's attention. One such disorder is diabetes, which...
Genmab A/S announced on Jan. 15 that its drug, Darzalex Faspro has been approved by the US Food and Drug Administration (FDA) for the treatment of...
Mammoth and IDbyDNA are among subcontractors under a four-year, up-to-$36.7 million CRISPR diagnostics contract inked by DoD’s Defense Advanced Research Projects Agency (DARPA) with prime contractor...
California Halts COVID Vaccinations From Moderna Batch Linked To "Unusually High Number" Of Adverse Reactions As the suspected death toll attributed to COVID-19 vaccines rises around...
Public health authorities in California are seeking a halt on dosing of one lot of Moderna’s COVID-19 vaccine.
A promise by president-elect Joe Biden to carry out 100 million coronavirus vaccinations in his first 100 days The post Fauci backs Biden’s plan for 100...
Developers of digital health tools have benefited from a truncated route to market during the COVID-19 crisis, and The post US eyes permanent change to digital...
Measuring mitochondrial DNA could predict who will need ICU care, intubation Credit: WANDY BEATTY One of the most vexing aspects of the COVID-19 pandemic is doctors’...
Low oxygen levels can be a sign that a patient is in danger. A device that measures oxygen levels has been shown to miss low oxygen...
One Of The Greatest Economic Blunders In History Authored by James Rickards via The Daily Reckoning, The U.S. economy lost 140,000 jobs in December. Only about...
Johnson & Johnson published interim Phase I/IIa data in the New England Journal of Medicine showing the company's single-dose Covid-19 vaccine candidate created an immune response
South Korea’s Celltrion has announced encouraging top-line results for its potential antibody therapy for COVID-19, with the first The post Celltrion closes in on COVID-19 antibody...
NextCure has found its new CMO after the previous executive resigned last August. Han Myint, a biopharma and academia veteran of more than 20 years, joined...
While pharma has raced to develop COVID-19 vaccines, US-based company NeuroRx is taking a different approach to treating The post A new approach to COVID-19 treatment...
J&J has announced early trial results that suggest its single-shot coronavirus vaccine provides a sustained response against the The post J&J single-shot COVID-19 vaccine shows early...
Janet Woodcock, the longtime director of the Center for Drug Evaluation and Research (CDER) at the U.S. Food and Drug Administration, is set to take over...
UK biotech Synairgen is pushing ahead with a phase 3 trial of SNG001 in hospitalize COVID-19 patients
Healthcare technology firm Seqster has introduced a new version of its service that aims to help pharma companies The post Seqster launches new cloud version of...
Wartime-level funding for a fleet of CO2 scrubbers could slow warming, but stopping climate change still requires deep cuts in emissions Credit: Credit: acilo/iStock There is...
J& J is on track to roll out a single-shot coronavirus vaccine in March, and plans to have clear data on how effective it is by...
'Orphan drugs' with high price points are being tested as treatments for COVID-19. There's a better way to spur low-cost innovation for new drugs.
BioSpace looks at some of the top stories from Day 2 of the virtual JP Morgan Annual Healthcare Conference.
Moncef Slaoui, the GlaxoSmithKline vaccines veteran who has helmed the federal government’s Operation Warp Speed Covid-19 vaccine program, is stepping down from the role ahead of...
Credit: Cody Duty/UTHealth Researchers evaluating whether an investigational oral drug, vadadustat, can help prevent acute respiratory distress syndrome (ARDS) in COVID-19 patients were awarded $5.1 million...
Regeneron Pharmaceuticals has signed an agreement with the U.S. for the additional supply of 1.25 million doses of its antibody cocktail for the use in non-hospitalized...
Credit: CWRU CLEVELAND–The combined effectiveness of three COVID-prevention strategies on college campuses–mask-wearing, social distancing, and routine testing–are as effective in preventing coronavirus infections as the Pfizer...
CNBC Exclusive: CNBC Transcript: Pfizer Chairman and CEO Albert Bourla speaks with CNBC’s “Squawk Box” today about the Covid vaccine manufacturing outlook. Q3 2020 hedge fund...
Antiviral protein MDA-5 senses viral replication and governs immune response to SARS-CoV-2 Credit: Sanford Burnham Prebys Medical Discovery Institute LA JOLLA, CALIF. – Jan 12, 2020...
ImmunityBio has licensed technology underpinning a COVID-19 vaccine that could be administered orally rather than by injection from The post Oral COVID-19 vaccine beckons, as ImmunityBio...